Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04406623
Title Phase 1 Study of SL-172154 (SIRPalpha-Fc-CD40L) in Subjects With Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Shattuck Labs, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91016 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
Stephenson Cancer Center at Oklahoma University Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field